Atul (500027) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
25 Aug, 2025Executive summary
Audited standalone and consolidated financial results for the year ended March 31, 2025, were approved, with unmodified audit opinions from Deloitte Haskins & Sells LLP.
Board recommended a dividend of ₹25 per equity share, subject to shareholder approval at the AGM on July 25, 2025.
Appointment of SPANJ & Associates as Secretarial Auditors for five years, pending AGM approval.
Financial highlights
Standalone revenue from operations for FY25 was ₹5,074.69 cr, up from ₹4,357.70 cr year-over-year; consolidated revenue was ₹5,583.35 cr, up from ₹4,725.68 cr.
Standalone net profit after tax for FY25 was ₹456.28 cr, up from ₹384.57 cr; consolidated net profit after tax was ₹498.83 cr, up from ₹324.12 cr.
Standalone EPS for FY25 was ₹154.98 (basic and diluted); consolidated EPS was ₹164.37.
Total comprehensive income for FY25 was ₹108.91 cr (standalone) and ₹91.02 cr (consolidated), reflecting significant negative fair value adjustments in OCI.
Outlook and guidance
Dividend of ₹25 per share recommended, with record date set for July 11, 2025, and payment on or after July 30, 2025, pending AGM approval.
Latest events from Atul
- Q3 FY26 consolidated net profit rose to ₹163.54 crore on revenue of ₹1,573.62 crore.500027
Q3 25/2623 Jan 2026 - Strong revenue and profit growth in H1 FY2025, led by core chemical segments.500027
Q2 25/2617 Oct 2025 - Strong revenue and profit growth driven by robust segment performance and clean audit review.500027
Q1 24/2525 Aug 2025 - Q2 FY25 saw strong revenue and profit growth, led by chemicals segments and robust margins.500027
Q2 24/2525 Aug 2025 - Q3 FY25 saw higher revenue and profit year-over-year, with robust segment performance.500027
Q3 24/2525 Aug 2025 - Consolidated revenue and profit rose year-over-year, led by strong chemical segment growth.500027
Q1 25/2625 Aug 2025